Drug Type Synthetic peptide |
Synonyms Cytotoxic PLA2 + [1] |
Target |
Mechanism PKC stimulants(Protein kinase C stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | - | - | |
Neoplasms | Phase 2 | - | - | |
Advanced cancer | Phase 1 | FR | 01 Aug 2024 |
Not Applicable | 6 | (cpwhyxwkrv) = Patient was hospitalised for observation and the event was classified as a possible study drug-related SAE as well as related to the digestive syndrome and tubulopathy resulting from previous chemotherapy (nivolumab and platinum salts) jkcyaheuhu (fzqtptziuk ) | - | 01 Jul 2018 |